Radar › Companies › Life Sciences · Misgav
Radar · Life Sciences in Misgav

Best Life Sciences Companies in Misgav, Israel

The 39 best Life Sciences companies in Misgav, Israel in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Biond Biologics.

39companies tracked
$133Mdisclosed funding
0unicorns
25have raised
FLIAR INTELLIGENCE · LIFE SCIENCES × MISGAV

Our analysis of 50 Life Sciences companies

$2.2b in tracked funding; 75% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2024.

50companies analysed
75%cloud-native stacks
2024funding peak (by rounds)
1unicorns
2014median founding year

Ranked: Best Life Sciences companies in Misgav

#CompanyDisclosed fundingLast roundEmployeesFounderStagePatents & IP focusRecent signals
1Biond Biologics
Developer of immunotherapies for oncology and autoimmune diseases
$32M57 mo ago34—Series C141 patents
Patents concentrated in chemistry & materials
—
2Vessi Medical
Provider of method for treating bladder cancer
$18M30 mo ago3—Series A——
3Mitrassist
Supplementary valve for mitral regurgitation treatment
$17M105 mo ago15—Series B——
4Escala Medical
Developing repair device for the treatment of pelvic organ prolapse (POP)
9Funding top 37%Global bottom 36%Market bottom 20%
All 3 signals ▾
Fundingtop 37%
Globalbottom 36%
Marketbottom 20%
Funding: Raised $13.1M across 3 rounds · 3 rounds over 3 yrs (1.0/yr)
Global: Investors from 2 countries beyond Israel
rank vs industry peers · Fliar Intelligence Index 9/100
$13M14 mo ago5—Series A——
5OrthoSpin
External fixation system for bone injuries, bone lengthening & limb deformities
$8M77 mo ago8—Acquired17 patents
Motorized, adjustable spinal strut implants for orthopedic fixation and correction
—
6Gordian Surgical
A trocar with an integrated closure system
$7M82 mo ago7—Series A20 patents
Laparoscopic trocar incision closure devices and assembly methods for surgical wound sealing
—
7ApiFix
Implant for treatment of scoliosis
$5M88 mo ago8—Acquired105 patents
Spinal implant systems with biasing and ratcheting mechanisms for adjustable fixation
—
8ProArc Medical
Developer of minimally invasive BPH treatment solutions
$5M61 mo ago7—Funding Raised39 patents
Urethral therapeutic devices and procedures for minimally invasive urinary tract treatment
—
9ElastiMed
Wearable compression stocking to prevent Deep vein thrombosis
$4M73 mo ago5—Seed43 patents
Electro‑active polymer medical compression and wearable devices, including pre‑stretch mechanisms.
—
10Fidmi Medical
Provider of an enteral feeding device for the treatment of gastrointestinal disorders
$4M58 mo ago3—Seed——
11Virtual Ports
Micro-anchoring technology for laparoscopic surgery
$4M171 mo ago8—Series A27 patents
Provides specialized minimally invasive surgical instruments and accessories for tissue manipulation and visualization.
—
12Nephera
Develops product to improve treatment of acute heart failures
$3M192 mo ago—Yair Feld
Founder & Director
Deadpooled11 patents
Medical devices and methods for stimulating urinary system function
—
13Helix Medical Systems
Ultrasound systems for breast imaging
$3M223 mo ago—Arie Amara
Co-Founder & ex-CEO
Deadpooled——
14ZygoFix
Provider of miniature screwless spine fusion implant
$2M53 mo ago4Ofer Levy
CEO
Seed18 patents
Spinal facet joint distraction and fusion prosthetic devices and delivery systems.
—
15SetBone Medical
Developer of bone cement for the treatment of vertebral compression fractures
$2M55 mo ago4Royi Kaufmann
Co-Founder & CEO
Seed——
16Ceretrieve
Developer of medical devices for treating ischemic stroke
$2M68 mo ago7Ronen Jaffe
Co-Founder
Seed16 patents
Medical devices for intravascular clot retrieval and catheter-based embolus removal
—
17Regenovation
Biotech drug development company working on drugs for tissue repair and regeneration
$1M133 mo ago—Andrew Pearlman
Co-Founder
Deadpooled——
18Juvenis
Developer of biopolymers for tissue augmentation & reconstruction
$1M173 mo ago—Lior Yankelson
Co-Founder
Seed9 patents
Injectable biodegradable polymer gels for soft tissue repair and augmentation
—
19Stimatix GI
Medical devices to aid patients with intestinal blockage or Crohn’s Disease
$1M186 mo ago8—Seed48 patents
Improved ostomy appliances with advanced gas filtration and sealing mechanisms.
—
20Deliverance
Developing catheters for the bleed management during surgeries
$700K168 mo ago—Dan Aravot
Co-Founder
Deadpooled7 patents
Endovascular devices for sealing vascular perforations and maintaining blood flow
—
21Arcuro Medical
Developer of a repair system for meniscus tears of the knee
$670K20 mo ago12—Series A——
22ST Stent
Flexible nasal stent
$450K93 mo ago3—Seed——

Top 12 Life Sciences companies in Misgav

#1
Series A · Misgav, Northern District · founded 2014 · 5 employees
$13.1Mraised
▾

Escala Medical is focussed on developing a device for the treatment of pelvic organ prolapse (POP). It has developed a device whose approach mirrors the surgery-based repair to fix the vaginal apex to the sacrospinous ligament (SSL). As of September 2016, the device is in technological development and claims to be a nonsurgical, incision-free, mesh-free repair approach.

Fliar Intelligence Index™ 9how this company ranks against its industry peers
Funding
top 37%
Global
bottom 36%
Market
bottom 20%
Funding: Raised $13.1M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) · Last round Series A (Jun 2025)
Global: Investors from 2 countries beyond Israel
Market: 5 employees
Audience (LinkedIn): 1k LinkedIn followers — 7.9% of this cohort's audience
Funding rounds
  • Jun 2025Series A$4.5M
  • Oct 2023Grant (prize money)$2.6M
  • Jun 2023Grant (prize money)—
  • Jun 2023Seed—
Investors
EIC Fund, Europa, The Trendlines Group, VentureHealth
#2
Series A · Misgav, Northern District · founded 2015 · 3 employees
$18.2Mraised
▾

Vessi Medical develops a method for treating Non-Muscle Invasive Bladder Cancer (NMIBC). The company uses surface cryotherapy, a method that utilizes extreme cold, to freeze and destroy abnormal tissue. The invasive solution for NMIBC provides a new, first-line, therapeutic alternative to surgery

Funding rounds
  • Feb 2024Series A$16.5M
  • Aug 2020Seed$1.7M
Investors
Agriline Products, Israel Innovation Authority, ExitValley, The Trendlines Group, ALIVE
#3
Series A · Misgav, Northern District · founded 2013 · 12 employees
$670Kraised
▾

Developer of a repair system for meniscus tears of the knee. It uses proprietary SuperBall repair system that has developed a knotless all-suture implant and a delivery system for meniscus repair. The system preserves meniscus functionality, repairs hard-to-reach areas, provides full meniscus coverage and is easy to operate.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers — 17.6% of this cohort's audience
Investors
The Trendlines Group, Naton, Varana Capital, Consensus Business Group
#4
Series C · Misgav, Northern District · founded 2016 · 34 employees
$32Mraised
▾

Developer of immunotherapies for oncology and autoimmune diseases. The lead candidate BND 22 is an immune checkpoint inhibitor for solid tumors, BION-206 is a VHH antibody, enhances phagocytosis, and BND-35 is an antibody targeting ILT3 receptor for the treatment of solid tumors. The INspire technology is a platform for the internalization of antibodies into cells, addressing “undruggable” intracellular targets.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers — 20.6% of this cohort's audience
Funding rounds
  • Nov 2021Series C$15M
  • Jan 2019Series B$17M
Investors
Harel Group, Celgene, SBI JI, Israel Biotech Fund, Deep Insight, Heritage
Tech stack
CloudflareCore-JsElementorHello ElementorHttp/3Jquery
#5
Funding Raised · Misgav, Northern District · founded 2010 · 7 employees
$4.5Mraised
▾

Developer of minimally invasive BPH treatment solutions. It offers a non-surgical procedure to restore urinary function and relieve symptoms associated with benign prostatic hyperplasia (BPH). The solution provides long-term efficacy with reduced risk, preserving sexual function and eliminating complications associated with traditional treatments. The procedure is minimally invasive, reversible, and offers immediate relief. The technology utilizes a unique tissue-embedding technique to maintain a clear urethral pathway.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 1k LinkedIn followers — 8.6% of this cohort's audience
Funding rounds
  • Jul 2021Grant (prize money)$59.4K
  • Aug 2019Grant (prize money)$2.2M
  • Jul 2019Grant (prize money)$2.2M
  • Apr 2018Grant (prize money)$60.6K
Investors
EIC Fund, Europa, The Trendlines Group
Tech stack
WordpressMysqlPhpHello ElementorElementorYoast Seo
#6
Series B · Misgav, Northern District · founded 2009 · 15 employees
$17Mraised
▾

MitrAssist is a medical devices company in the cardiology field. It aims to provide a minimally invasive solution for the treatment of mitral regurgitation (MR). The proprietary valve implant is neither repair nor replacement, instead, it is placed on top of the natural valve to work in unison with it and to enhance valve functionality.

Funding rounds
  • Nov 2017Series B$16M
  • Jul 2013Angel$1M
Investors
Ping An, The Trendlines Group, Hermed Capital
Tech stack
PleskWindows ServerMicrosoft Asp.NetIis
#7
Series A · Misgav, Northern District · founded 2012 · 7 employees
$7.2Mraised
▾

Gordian Surgical is developing a trocar with an integrated closure system that provides a suture-anchored fascia closure for improved laparoscopic procedures. Their two-in-one trocar can be adapted to different types of trocars including bladed/bladeless, disposable/multiuse, and others

LinkedIn Pulse recent public activity · Jul 2026
Audience: 568 LinkedIn followers — 4.3% of this cohort's audience
Activity: 1 product launches · 1 partnerships (incl. Avio Medtech Consulting) announced in 12 mo
Funding rounds
  • Oct 2019Series A$3M
  • Dec 2016Series A$2.2M
  • Oct 2015Series A$1M
  • Apr 2014Series A$1M
Investors
VI Ventures, B Braun, The Trendlines Group, Pirveli Ventures, Campus Founders Fund
Tech stack
WixReactGoogle CloudHstsGoogle Cloud CdnHttp/3
#8
Seed · Misgav, Northern District · founded 2015 · 5 employees
$4.2Mraised
▾

ElastiMed is developing a wearable compression device, to improve blood circulation in the lower extremity by mimicking rhythmic calf muscle contractions and stimulating blood flow. The compression stocking has applications in the treatment of treatment of CVI (Chronic Venous Insufficiency), Lymphedema and prevention of DVT (Deep Vein Thrombosis). Based on proprietary technology utilizing smart materials, ElastiMed’s stocking stretches and contracts when stimulated by an electric pulse (generated by a 3V battery). The company claims that these unique capabilities combined with low-cost materials and a high level of control, enables the ElastiMed stocking to provide patients with a highly effective and easy-to-wear, affordable treatment option. The products are targeted at the compression therapy market, which was estimated at $2.2B worldwide in 2014. The company is backed by Trendlines, an Israel-based innovation commercialization company.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 722 LinkedIn followers — 5.5% of this cohort's audience
Hiring: 1 hiring post in 12 mo (public) · hiring: Head of QA & Regulatory Affairs
Funding rounds
  • Aug 2020Seed$600K
  • Jun 2020Grant (prize money)$56.2K
  • Jun 2018Grant (prize money)$1.6M
  • Sep 2017Grant (prize money)$59K
Investors
Europa, Pix Vine Capital, EIC Fund, The Trendlines Group, Israel Innovation Authority, Typewiser
Tech stack
Nginx
#9
Acquired · Misgav, Northern District · founded 2014 · 8 employees
$8Mraised
▾

OrthoSpin is focussed on developing a smart external fixation system for bone injuries, bone lengthening & limb deformities. It has developed a hexapod-shaped external frame system that stabilizes broken bones until healing occurs. The system automatically and continuously adjusts and lengthens the struts according to the prescribed treatment regimen. It also developed a proprietary software program which allows physicians to chart patient progress and to change the treatment schedule.

Funding rounds
  • Mar 2020Series B$5M
  • Jul 2018Series A$3M
  • Dec 2015Seed—
Investors
Johnson & Johnson Innovation, The Trendlines Group
#10
Seed · Misgav, Northern District · founded 2014 · 3 employees
$4.2Mraised
▾

Provider of an enteral feeding device for the treatment of gastrointestinal disorders. The company product includes a PEG device disposable feeding tube with an internal bumper that enables to prevent dislodgment and breaks apart for trauma.

Investors
B Braun, Europa, EIC Fund, Nanjing Minimally Medical Technology, The Trendlines Group, Agriline Products
#11
Seed · Misgav, Northern District · founded 2016 · 4 employees
$2Mraised
▾

Provider of miniature screwless spine fusion implant. The company offers zLOCK SI to treat SI dysfunction, zLOCK Cervical is used to stabilize and treat spinal stenosis, zLOCK lumbar is used to treat spinal stenosis and facet arthritis.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers — 17.0% of this cohort's audience
Activity: 2 product launches announced in 12 mo
Founders & team
Ofer LevyCEO
Investors
MassChallenge, The Trendlines Group, Israel Innovation Authority, Europa, EIC Fund
Tech stack
WixReactGoogle CloudSectigoHstsGoogle Cloud Cdn
#12
Acquired · Misgav, Northern District · founded 2011 · 8 employees
$5Mraised
▾

ApiFix offers an "internal brace” to correct the spinal curve and maintain it. The ApiFix Internal Brace System is attached to the spine via 2 pedicle screws in an hour long procedure. The expandable rod between the two screws uses a miniature ratchet mechanism that captures incremental deformity corrections at the time of patient is performs side bending exercises to the corrective direction, at home, for 6 months after the operation.The long, incremental process reduces the load on the screws and allows the body to rebuild itself in the correct position. Product is CE Marked.

Funding rounds
  • May 2019Grant (prize money)$50K
  • Apr 2019Series B—
  • Nov 2016Series B$5M
  • Oct 2013Series B—
Investors
The Trendlines Group, MedTech Innovator, ADIP
Tech stack
WordpressMysqlPhpYoutubeVimeoYoast Seo

Funding & investor landscape

$133Mtotal disclosed funding
24companies funded
43disclosed rounds
0rounds last 90 days
Most active investors
The Trendlines Group30 rounds
Europa7 rounds
EIC Fund6 rounds
Agriline Products3 rounds
Israel Innovation Authority3 rounds
B Braun2 rounds
Israel Biotech Fund2 rounds
MassChallenge2 rounds
Pontifax2 rounds
ADIP1 rounds

Notable founders

Ofer Levy
CEO · ZygoFix
Royi Kaufmann
Co-Founder & CEO · SetBone Medical
Maysa Mustafa
CEO · Ceretrieve
Ronen Jaffe
Co-Founder · Ceretrieve
Arie Amara
Co-Founder & ex-CEO · Helix Medical Systems
Ron Hadani
Co-Founder & President · Helix Medical Systems
Yair Feld
Founder & Director · Nephera
Andrew Pearlman
Co-Founder · Regenovation
Lior Yankelson
Co-Founder · Juvenis
Winston Goode
Co-Founder · Juvenis
Dan Aravot
Co-Founder · Deliverance
Amir Marmor
Founder & CEO · CorAlert
Prism market signals · Israel · country-scoped Prism corpus, 1,211,671 docs

Market landscape — 10 sub-themes by coverage

Share of Life Sciences coverage by sub-theme.

Regulatory-risk over time rising

Funding & growth over time

funding rising · growth rising

RESEARCH SIGNALS · Israel

How research on Biotechnology is moving in Israel

A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 267 Israel-affiliated papers.

top research entities
  • Ministry of Agriculture118
  • Hebrew University of Jerusalem29
  • Agricultural Research Organization25
  • Tel Aviv University21
  • Ben-Gurion University of the Negev19
leading researchers
Itamar Willner · Dombrovsky, A. · Wei Zhao · Goor Sasson · Roy Novoselsky · Shalev Itzkovitz · Xiaoqing Liu · Hengyou Zhang
▲ Breakthroughs69 · 26%
▲ 0%→25% share
0 median citations80% since 2021mostly empirical
Breakthroughs are rising (0%→25% of field), led by Mitochondrion.
rising sub-themes (early→recent)
  • Mitochondrion1→5
Newly emergingGene 0→10 · Transcription factor 0→5 · Mutant 0→5
Landmark The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity · 3,514 cites
◆ Advancements119 · 45%
▲ 0%→48% share
0 median citations90% since 2021mostly empirical
Advancements are rising (0%→48% of field), led by Gene.
rising sub-themes (early→recent)
  • Gene1→18
  • Plant disease resistance1→7
  • Resistance (ecology)2→6
Newly emergingTranscriptome 0→8 · Microbiome 0→8 · Selection (genetic algorithm) 0→7
Landmark Plant Growth-Promoting Rhizobacteria: Context, Mechanisms of Action, and Roadmap to Commercialization of Biostimulants f · 1,849 cites
▼ Concerns43 · 16%
▲ 0%→14% share
0 median citations74% since 2021mostly reviews
Concerns are rising (0%→14% of field), led by Agriculture.
rising sub-themes (early→recent)
  • Agriculture3→6
Landmark Genetic Engineering for Modern Agriculture: Challenges and Perspectives · 1,148 cites
RESEARCH HOTSPOTS · Israel

Where biotechnology is researched across Israel

Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.

Jerusalem29 · +0.39
Opportunity · Transcriptome
Tel Aviv27 · +0.41
Advancing · Molecular biologyOpportunity · Selection (genetic algorithm)
Beer Sheva19 · +0.60
Opportunity · Gene
Haifa17 · +0.40
Opportunity · Biomass (ecology)
Rehovot16 · +0.53
Advancing · Cell biologyOpportunity · Subcellular localization

Common questions

How many Life Sciences companies are there in Misgav, Israel?
Radar tracks 39 indexable Life Sciences companies headquartered in Misgav, Israel that meet our profile-completeness bar.
What is the total funding raised by Life Sciences companies in Misgav, Israel?
The Life Sciences companies in Misgav, Israel on this list have raised a combined $133M in disclosed equity funding across 24 funded companies.
Which is the highest-funded Life Sciences company in Misgav, Israel?
Biond Biologics is the highest-funded Life Sciences company in Misgav, Israel, with $32M in disclosed equity funding.
How many Life Sciences companies in Misgav, Israel are funded?
24 of the 39 Life Sciences companies in Misgav, Israel on this list have disclosed at least one equity funding round.
How many Life Sciences unicorns are there in Misgav, Israel?
None of the Life Sciences companies in Misgav, Israel on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Misgav, Israel Life Sciences companies?
The most active investors in Misgav, Israel Life Sciences companies on this list include The Trendlines Group, Europa, EIC Fund, Agriline Products, Israel Innovation Authority.
Rohit KhannaTrends & Stories

Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.

Coming soon